GOCOQ (GoHealth) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


GOCOQ GoHealth Inc GOCOQ
38 GF Score
Price $0.40
GF Value $1.60
Valuation Possible Value Trap
! 10 Warning Signs
View Full Analysis

What is GoHealth Research & Development?

GoHealth GOCOQ +4.83% 38 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates GOCOQ with a GF Score™ of 38/100 and a GF Value™ of $1.60 (Possible Value Trap). The stock has 10 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. GoHealth's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

GoHealth  (OTCPK:GOCOQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

GoHealth Research & Development Related Terms

GoHealth Research & Development Historical Data

* Premium members only.

The historical data trend for GoHealth's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GoHealth Research & Development Chart

GoHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

GoHealth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
GOCOQ
38GF Score
GoHealth Inc GOCOQ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GoHealth Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
GoHealth (GOCOQ) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on GoHealth and its competitors.
Is GoHealth's Research & Development too high?
GoHealth's current Research & Development is $0.0 Mil. Overall, GoHealth has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoHealth's Research & Development compare to HUIZ and EZRA?
GoHealth's Research & Development of $0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on GoHealth and its competitors. GoHealth's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoHealth stock overvalued right now?
Based on GuruFocus' analysis, GoHealth (GOCOQ) is currently considered Possible Value Trap. The stock's GF Value™ is $1.60, compared to a current price of $0.40 — trading 75.3% below its estimated fair value. The current Research & Development is $0.0 Mil. GoHealth's overall GF Score™ is 38/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For GoHealth (GOCOQ), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GoHealth (GOCOQ) Overvalued in 2026?

Based on GuruFocus' analysis, GoHealth stock appears to be undervalued. The current stock price of $0.40 is trading 75.3% below its estimated GF Value™ of $1.60. GuruFocus considers GoHealth to be Possible Value Trap.

Key valuation signals for GOCOQ:

  • Research & Development: $0.0 Mil
  • GF Value™: $1.60 vs. price of $0.40 (75.3% below fair value)
  • GF Score™: 38/100 with 10 warning signs

No single metric tells the full story. See the GOCOQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GoHealth Business Description

Address 222 W Merchandise Mart Plaza, Suite 1750, Chicago, IL, USA, 60654
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions, so it can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. The proprietary technology platform integrates artificial intelligence and modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.
38GF Score

Get the complete analysis for GOCOQ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$1.60
GF Value